Decision Diagnostics Closes $12.5 Million (Non-Dilutive) Credit Facility With Division of Platinum Credit Management

Decision Diagnostics Closes $12.5 Million (Non-Dilutive) Credit Facility With 
Division of Platinum Credit Management 
New 5-Year Credit Facility Amounts to Revolving Financing Greater
Than $250+ Million Annually; Current Trade Debt of Approx. $2.9
Million to Be Completely Retired, Cleaning and Enhancing Balance
Sheet in Advance of Uplisting; Company and Platinum Are Also in Final
Discussions for a Litigation Line of Credit to Pursue J&J/Lifescan 
LOS ANGELES, CA -- (Marketwired) -- 12/19/13 --  Decision Diagnostics
Corp. (OTCBB: DECN) the exclusive worldwide sales, service and
regulatory processes agent for the popular Shasta GenStrip(TM), the
unique Green Glucose Test Strip, specifically designed to work with
the Johnson & Johnson's (NYSE: JNJ) LifeScan Ultra family of glucose
testing meters, today announced that that the Company has closed its
agreement for a $12.5 million revolving credit line from Alpha Credit
Resources, LLC, a division of Platinum Credit Management LP of New
York, NY.  
The company also announced that the new $12.5 million credit line
will be equity free (no share dilution) and when matched with the
company's current 1.8X sales turns per month (velocity), this credit
facility will finance company sales of its GenStrip product line
through $250+ million annually. Finally, the company announced that
it is in discussions with Platinum to fund the prosecution of the
company's Anti-trust lawsuit against J&J/Lifescan.  
"This credit line provides substantial resources for the Company to
initiate our aggressive and time sensitive GenStrip business
strategies," commented Keith Berman, DECN's Principal Officer, CFO
and the GenStrip Program Director. "We want to make it clear to our
shareholders, and the investing public, that our commercial lender
Platinum Credit Management does not view Decision Diagnostics as a
small business." 
Mr. Berman continued, "We are in final discussions to back up our new
$12.5 million credit line with an additional line to fund the
company's prosecution of J&J/Lifescan. As many are aware, judgments
in Anti-trust suits can include awards of triple damages. Litigation
prosecution pools are very popular instruments, often only available
to the largest of companies or those with the strongest of cases to
prosecute." 
Decision Diagnostics has been in the news recently. If you are
interested in following DECN in the news, please press the links
below: 
http://www.decisiondiagnostics.com/documents/20131217dealarticle.html 
http://www.marketwired.com/press-release/decision-diagnostics-receives-mandate-from-us-court-appeals-federal-circuit-long-running-otcbb-decn-1863142.htm 
http://www.marketwired.com/press-release/decision-diagnostics-board-votes-to-uplist-to-otc-qx-otcbb-decn-1860852.htm 
Mr. Berman continued, "DECN never had to turn to stock market
arbitrages such as equity lines of credit, equity participation
agreements or any other type of toxic financing to secure this $12.5
million line of credit. In fact there is no on-going equity provision
period. With the significant revenue streams GenStrip will produce,
when coupled with our renewed access to $12.5 million of growth
capital, we are now well positioned to complete the launch of
GenStrip and embark on our two missions, branding GenStrip and
defeating J&J/Lifescan in court. " 
Forward-Looking Statements:
 This release contains forward-looking
statements about our business or financial condition that reflect our
assumptions and beliefs based on information currently available. We
can give no assurance that the expectations indicated by such
forward-looking statements will be realized. There may be other risks
and circumstances that we are unable to predict. When used in this
release, words such as "believes," "expects," "forecasts," "intends,"
"projects," "plans," "anticipates," "estimates," "will" and similar
expressions are intended to identify forward-looking statements,
although there may be certain statements not accompanied by such
expressions.  
For further information about Shasta GenStrip, please visit the
company's Web Sites: http://www.decisiondiagnostics.com/ or
http://www.shastagenstrip.com/. The company also reminds all
interested parties that the airing of its commercial video titled
"GenStrip: A Patchwork of Life began on November 1 and will continue.
We are currently filming additional Patchwork of Life commercials.
And in the meantime the extremely popular video is available for
viewing at: http://shastagenstrip.com/shasta_ad.html or
http://youtu.be/zzBuHxb-rlM.  
GenStrip(TM) test strips are a product of Shasta Technologies, LLC
and are not manufactured, distributed, endorsed, or approved by nor
associated with LifeScan(R), Inc. a Johnson & Johnson(R) Company,
manufacturers and distributors of the OneTouch(R) Ultra(R) Family of
Meters and OneTouch(R) Ultra(R) test strips purchased prior to July
2013.  
Decision Diagnostics Corp. 
Keith Berman 
(805) 446-2973 
info@decisiondiagnostics.com 
 
 
Press spacebar to pause and continue. Press esc to stop.